Literature DB >> 8670538

Assessment of activities of daily living in dementia: development of the Bristol Activities of Daily Living Scale.

R S Bucks1, D L Ashworth, G K Wilcock, K Siegfried.   

Abstract

A new assessment of Activities of Daily Living has been developed specifically for use with people with dementia. The assessment is a carer rated instrument consisting of 20 daily-living abilities. The scale has 'face validity', assessing items rated as important by and using levels of ability generated by carers. It has 'construct' validity as demonstrated by principal components analysis. It has 'concurrent' validity in that it correlates well with observed task performance. It has good 'test-retest' reliability as measured by Cohen's Kappa and it correlates well with the Mini-Mental State Examination. Carers report that it is easy to use and it is relatively short. The authors believe the scale will be useful when assessing demented patients in the community or as part of clinical research trials.

Entities:  

Mesh:

Year:  1996        PMID: 8670538     DOI: 10.1093/ageing/25.2.113

Source DB:  PubMed          Journal:  Age Ageing        ISSN: 0002-0729            Impact factor:   10.668


  133 in total

1.  Effectiveness of rivastigmine in Alzheimer's disease. Participation in trials should be based on clinical uncertainty, not enforcement.

Authors:  R Bullock; P Passmore; D Wilkinson; R Howard; R Jones
Journal:  BMJ       Date:  2000-02-19

2.  Relationships between balance control and cognitive functions, gait speed, and activities of daily living.

Authors:  Magdaléna Hagovská; Zuzana Olekszyová
Journal:  Z Gerontol Geriatr       Date:  2015-10-12       Impact factor: 1.281

Review 3.  Withdrawal of Antidementia Drugs in Older People: Who, When and How?

Authors:  Carole Parsons
Journal:  Drugs Aging       Date:  2016-08       Impact factor: 3.923

Review 4.  Assessment of physical functioning: a conceptual model encompassing environmental factors and individual compensation strategies.

Authors:  Kristin M Tomey; Maryfran R Sowers
Journal:  Phys Ther       Date:  2009-05-14

5.  Improving access to dementia care: development and evaluation of a rural and remote memory clinic.

Authors:  Debra G Morgan; Margaret Crossley; Andrew Kirk; Carl D'Arcy; Norma Stewart; Jay Biem; Dorothy Forbes; Sheri Harder; Jenny Basran; Vanina Dal Bello-Haas; Lesley McBain
Journal:  Aging Ment Health       Date:  2009-01       Impact factor: 3.658

6.  Etanercept in Alzheimer disease: A randomized, placebo-controlled, double-blind, phase 2 trial.

Authors:  Joseph Butchart; Laura Brook; Vivienne Hopkins; Jessica Teeling; Ursula Püntener; David Culliford; Richard Sharples; Saif Sharif; Brady McFarlane; Rachel Raybould; Rhodri Thomas; Peter Passmore; V Hugh Perry; Clive Holmes
Journal:  Neurology       Date:  2015-05-01       Impact factor: 9.910

7.  The most problematic symptoms of prion disease - an analysis of carer experiences.

Authors:  Liz Ford; Peter Rudge; Kathy Robinson; John Collinge; Michele Gorham; Simon Mead
Journal:  Int Psychogeriatr       Date:  2019-08       Impact factor: 3.878

8.  Late onset Alzheimer's disease and apolipoprotein association in the Irish population: relative risk and attributable fraction.

Authors:  Z Hawi; K Sheehan; A Lynch; I Evans; N Lowe; B Lawlor; M Gill
Journal:  Ir J Med Sci       Date:  2003 Apr-Jun       Impact factor: 1.568

9.  DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease - a multicentre RCT.

Authors:  Rob Jones; Bart Sheehan; Patrick Phillips; Ed Juszczak; Jessica Adams; Ashley Baldwin; Clive Ballard; Sube Banerjee; Bob Barber; Peter Bentham; Richard Brown; Alistair Burns; Tom Dening; David Findlay; Richard Gray; Mary Griffin; Clive Holmes; Alan Hughes; Robin Jacoby; Tony Johnson; Roy Jones; Martin Knapp; James Lindesay; Ian McKeith; Rupert McShane; Ajay Macharouthu; John O'Brien; Caroline Onions; Peter Passmore; James Raftery; Craig Ritchie; Rob Howard
Journal:  Trials       Date:  2009-07-24       Impact factor: 2.279

Review 10.  Economic considerations in the management of Alzheimer's disease.

Authors:  Carolyn W Zhu; Mary Sano
Journal:  Clin Interv Aging       Date:  2006       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.